Effects on heavy menstrual bleeding and pregnancy of uterine artery embolization (UAE) or myomectomy for women with uterine fibroids wishing to avoid hysterectomy: the FEMME randomized controlled trial

Sirkeci, F., Moss, J., Belli, A. M., McPherson, K., Daniels, J., Manyonda, I., Middleton, L., Cheed, V., Wu, O. and Lumsden, M. A. (2023) Effects on heavy menstrual bleeding and pregnancy of uterine artery embolization (UAE) or myomectomy for women with uterine fibroids wishing to avoid hysterectomy: the FEMME randomized controlled trial. International Journal of Gynecology and Obstetrics, 160(2), pp. 492-501. (doi: 10.1002/ijgo.14626) (PMID:36511801)

[img] Text
288548.pdf - Published Version
Available under License Creative Commons Attribution.

1MB

Abstract

Objective: To determine treatment options (myomectomy vs uterine artery embolization [UAE]) for women wishing to avoid hysterectomy. Methods: A multicenter randomized controlled trial was conducted on 254 women and data were collected on fibroid-specific quality of life (UFS-QOL), loss of menstrual blood, and pregnancy. Results: At 4 years, the mean difference in the UFS-QOL was 5.0 points (95% confidence interval [CI] −1.4 to 11.5; P=0.13) in favor of myomectomy. This was not statistically significant as it was at 2 years. There were no differences in bleeding scores, rates of amenorrhea, or heavy bleeding. Of those who were still menstruating, the majority reported regular or fairly regular periods: 36 of 48 (75%) in the UAE group and 30 of 39 (77%) in the myomectomy group. Twelve women after UAE and six women after myomectomy became pregnant (4 years) with seven and five live births, respectively (hazard ratio 0.48, 95% CI 0.18–1.28). There was no difference between the levels of hormones associated with the uterine reserve in each group. Conclusion: Leiomyoma are common in reproductive-aged women, causing heavy menses and subfertility. Among women with uterine fibroids, myomectomy resulted in better fibroid-related quality of life at 4 years, compared with UAE but the treatments decreased menstrual bleeding equally. There was also no significant difference in the impact of treatment on ovarian reserve.

Item Type:Articles
Keywords:Uterine fibroid, myomectomy, uterine artery embolization, quality of life, United Kingdom, pregnancy rate, female, ovarian reserve.
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Wu, Professor Olivia and Lumsden, Professor Mary
Authors: Sirkeci, F., Moss, J., Belli, A. M., McPherson, K., Daniels, J., Manyonda, I., Middleton, L., Cheed, V., Wu, O., and Lumsden, M. A.
College/School:College of Medical Veterinary and Life Sciences > School of Health & Wellbeing > Health Economics and Health Technology Assessment
College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing
Journal Name:International Journal of Gynecology and Obstetrics
Publisher:Wiley
ISSN:0020-7292
ISSN (Online):1879-3479
Published Online:13 December 2022
Copyright Holders:Copyright © 2022 The Authors
First Published:First published in International Journal of Gynecology and Obstetrics 160(2): 492-501
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record

Project CodeAward NoProject NamePrincipal InvestigatorFunder's NameFunder RefLead Dept
190504A prospective randomised trial of myomectomy versus uterine artery embolisation (UAE) for women with uterine fibroids who wish to retain or improve their fertility (FEMME)Mary LumsdenNational Institute for Health Research (NIHR)08/53/22Med - Reproductive and Maternal Medicine